FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1439-1441 October 4, 2007 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Nichol, K. L. PubMed Citation

Annual administration of inactivated influenza vaccine to older adults has long been recommended by public health authorities.¹ The risks of influenza-related complications, hospitalizations, and deaths increase with age, as does the prevalence of underlying medical conditions. Prospective, randomized, controlled studies have demonstrated that inactivated vaccine is protective against laboratory-confirmed influenza in young adults and, according to much more limited data, in older adults as well.²

Since the vaccine reduces the risk of influenza, it would be reasonable to expect that vaccination would also reduce the risks of influenza-related complications in recipients. Demonstrating this type of effect in a prospective, randomized, . . . [Full Text of this Article]

Source Information

From the Infectious Disease Unit, University of Rochester Medical Center, Rochester, NY.

This article has been cited by other articles:

• (2007). Another Nod for the Flu Vaccine. JWatch General 2007: 1-1 [Full Text]  
• (2007). Long-Term Effectiveness of Flu Vaccine in Community-Dwelling Elderly Persons. JWatch Infect. Diseases 2007: 1-1 [Full Text]